These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 21166955

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. PJ-34 inhibits PARP-1 expression and ERK phosphorylation in glioma-conditioned brain microvascular endothelial cells.
    Motta C, D'Angeli F, Scalia M, Satriano C, Barbagallo D, Naletova I, Anfuso CD, Lupo G, Spina-Purrello V.
    Eur J Pharmacol; 2015 Aug 15; 761():55-64. PubMed ID: 25934569
    [Abstract] [Full Text] [Related]

  • 3. Selective inhibition of PDGFR by imatinib elicits the sustained activation of ERK and downstream receptor signaling in malignant glioma cells.
    Dong Y, Jia L, Wang X, Tan X, Xu J, Deng Z, Jiang T, Rainov NG, Li B, Ren H.
    Int J Oncol; 2011 Feb 15; 38(2):555-69. PubMed ID: 21152856
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
    Kim CK, Joe YA, Lee SK, Kim EK, O E, Kim HK, Oh BJ, Hong SH, Hong YK.
    Cancer Lett; 2010 Feb 28; 288(2):251-60. PubMed ID: 19664879
    [Abstract] [Full Text] [Related]

  • 5. Nobiletin induces inhibitions of Ras activity and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling to suppress cell proliferation in C6 rat glioma cells.
    Aoki K, Yokosuka A, Mimaki Y, Fukunaga K, Yamakuni T.
    Biol Pharm Bull; 2013 Feb 28; 36(4):540-7. PubMed ID: 23546290
    [Abstract] [Full Text] [Related]

  • 6. T11TS inhibits Angiopoietin-1/Tie-2 signaling, EGFR activation and Raf/MEK/ERK pathway in brain endothelial cells restraining angiogenesis in glioma model.
    Bhattacharya D, Chaudhuri S, Singh MK, Chaudhuri S.
    Exp Mol Pathol; 2015 Jun 28; 98(3):455-66. PubMed ID: 25797371
    [Abstract] [Full Text] [Related]

  • 7. Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo.
    Deng L, Li G, Li R, Liu Q, He Q, Zhang J.
    Cancer Biol Ther; 2010 Jun 01; 9(11):875-84. PubMed ID: 20364104
    [Abstract] [Full Text] [Related]

  • 8. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
    Chen XY, Dun JN, Miao QF, Zhang YJ.
    Pharmacology; 2009 Jun 01; 83(2):67-79. PubMed ID: 19052484
    [Abstract] [Full Text] [Related]

  • 9. Involvement of Rho-kinase in tumor necrosis factor-alpha-induced interleukin-6 release from C6 glioma cells.
    Yamaguchi S, Tanabe K, Takai S, Matsushima-Nishiwaki R, Adachi S, Iida H, Kozawa O, Dohi S.
    Neurochem Int; 2009 Nov 01; 55(6):438-45. PubMed ID: 19427347
    [Abstract] [Full Text] [Related]

  • 10. Cytosolic and calcium-independent phospholipase A(2) mediate glioma-enhanced proangiogenic activity of brain endothelial cells.
    Giurdanella G, Motta C, Muriana S, Arena V, Anfuso CD, Lupo G, Alberghina M.
    Microvasc Res; 2011 Jan 01; 81(1):1-17. PubMed ID: 21094175
    [Abstract] [Full Text] [Related]

  • 11. Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells.
    Das G, Shiras A, Shanmuganandam K, Shastry P.
    Mol Carcinog; 2011 Jun 01; 50(6):412-23. PubMed ID: 21557327
    [Abstract] [Full Text] [Related]

  • 12. RhoA/ROCK pathway inhibition by fasudil suppresses the vasculogenic mimicry of U2OS osteosarcoma cells in vitro.
    Xia Y, Cai X, Fan J, Zhang L, Li Z, Ren J, Wu G, Zhu F.
    Anticancer Drugs; 2017 Jun 01; 28(5):514-521. PubMed ID: 28225457
    [Abstract] [Full Text] [Related]

  • 13. Antiangiogenic properties of fasudil, a potent Rho-Kinase inhibitor.
    Hata Y, Miura M, Nakao S, Kawahara S, Kita T, Ishibashi T.
    Jpn J Ophthalmol; 2008 Jun 01; 52(1):16-23. PubMed ID: 18369695
    [Abstract] [Full Text] [Related]

  • 14. Emodin suppresses hyaluronic acid-induced MMP-9 secretion and invasion of glioma cells.
    Kim MS, Park MJ, Kim SJ, Lee CH, Yoo H, Shin SH, Song ES, Lee SH.
    Int J Oncol; 2005 Sep 01; 27(3):839-46. PubMed ID: 16077936
    [Abstract] [Full Text] [Related]

  • 15. Rho kinase inhibition by fasudil suppresses lipopolysaccharide-induced apoptosis of rat pulmonary microvascular endothelial cells via JNK and p38 MAPK pathway.
    Liu H, Chen X, Han Y, Li C, Chen P, Su S, Zhang Y, Pan Z.
    Biomed Pharmacother; 2014 Apr 01; 68(3):267-75. PubMed ID: 24406296
    [Abstract] [Full Text] [Related]

  • 16. Fucoidan/FGF-2 induces angiogenesis through JNK- and p38-mediated activation of AKT/MMP-2 signalling.
    Kim BS, Park JY, Kang HJ, Kim HJ, Lee J.
    Biochem Biophys Res Commun; 2014 Aug 08; 450(4):1333-8. PubMed ID: 25003321
    [Abstract] [Full Text] [Related]

  • 17. Fasudil hydrochloride hydrate, a Rho-kinase (ROCK) inhibitor, suppresses collagen production and enhances collagenase activity in hepatic stellate cells.
    Fukushima M, Nakamuta M, Kohjima M, Kotoh K, Enjoji M, Kobayashi N, Nawata H.
    Liver Int; 2005 Aug 08; 25(4):829-38. PubMed ID: 15998434
    [Abstract] [Full Text] [Related]

  • 18. Rho Kinase Inhibitor Fasudil Suppresses the Vasculogenic Mimicry of B16 Mouse Melanoma Cells Both In Vitro and In Vivo.
    Xia Y, Cai XY, Fan JQ, Zhang LL, Ren JH, Chen J, Li ZY, Zhang RG, Zhu F, Wu G.
    Mol Cancer Ther; 2015 Jul 08; 14(7):1582-90. PubMed ID: 25934709
    [Abstract] [Full Text] [Related]

  • 19. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y, Hu J, Ma J, Feng K, Zhang X, Yang S, Wang W, Zhang J, Zhang Y.
    Eur J Cancer; 2011 Oct 08; 47(15):2353-63. PubMed ID: 21680174
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of Rho-dependent kinases ROCK I/II activates VEGF-driven retinal neovascularization and sprouting angiogenesis.
    Kroll J, Epting D, Kern K, Dietz CT, Feng Y, Hammes HP, Wieland T, Augustin HG.
    Am J Physiol Heart Circ Physiol; 2009 Mar 08; 296(3):H893-9. PubMed ID: 19181962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.